Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than neuroprotection after focal cerebral ischemia

Neurobiology of Disease

Volumn 83, Issue , 2015, Pages 16-25

  Hermann, Dirk M ^a   Zechariah, Anil ^a,b   Kaltwasser, Britta ^a   Bosche, Bert ^a,c   Caglayan, Ahmet B ^d   Kilic, Ertugrul ^d   Doeppner, Thorsten R ^a,d  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF CALGARY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Cerebral ischemia; Neurogenesis; Neuroprotection; Neuroregeneration; Stroke

Indexed keywords

CASPASE 3; GELATINASE B; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HEME OXYGENASE 1; MALONALDEHYDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; RESVERATROL; SIRTUIN 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VASCULOTROPIN; SIRT1 PROTEIN, MOUSE; STILBENE DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN TISSUE; CELL SURVIVAL; CONTROLLED STUDY; CORNER TURN TEST; DRUG MECHANISM; ENZYME ACTIVITY; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; HISTOLOGY; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ROTAROD TEST; TIGHT ROPE TEST; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; CELL DEATH; CEREBRAL ARTERY DISEASE; CONVALESCENCE; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGENESIS; NEURONS; OXIDATIVE STRESS; RECOVERY OF FUNCTION; ROTAROD PERFORMANCE TEST; SIGNAL TRANSDUCTION; SIRTUIN 1; STILBENES; STROKE;

EID: 84941055204     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.08.018     Document Type: Article

References (45)

1. Agatonovic-Kustrin S., et al. Analysis of phenolics in wine by high performance thin-layer chromatography with gradient elution and high resolution plate imaging. J. Pharm. Biomed. Anal. 2015, 102:93-99.
2. Camont L., et al. Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions. Anal. Chim. Acta 2009, 634:121-128.
3. Capiralla H., et al. Resveratrol mitigates lipopolysaccharide- and Abeta-mediated microglial inflammation by inhibiting the TLR4/NF-kappaB/STAT signaling cascade. J. Neurochem. 2012, 120:461-472.
4. Catalgol B., et al. Resveratrol: French paradox revisited. Front. Pharmacol. 2012, 3:141.
5. Chen P.L., Easton A.S. Anti-angiogenic effects of resveratrol on cerebral angiogenesis. Curr. Neurovasc. Res. 2011, 8:14-24.
6. Chiba Y., et al. Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia. Kobe J. Med. Sci. 2008, 54:E136-E146.
7. Clark D., et al. Protection against recurrent stroke with resveratrol: endothelial protection. PLoS One 2012, 7:e47792.
8. Dirnagl U., et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007, 38:770-773.
9. Doeppner T.R., et al. Enhancement of endogenous neurogenesis in ephrin-B3 deficient mice after transient focal cerebral ischemia. Acta Neuropathol. 2011, 122:429-442.
10. Doeppner T.R., et al. Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation. Stem Cells 2012, 30:1297-1310.
11. Doeppner T.R., et al. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis. Brain 2012, 135:3282-3297.
12. Doeppner T.R., et al. MicroRNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradation. Acta Neuropathol. 2013, 126:251-265.
13. Doeppner T.R., et al. Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests. Front. Cell. Neurosci. 2014, 8:338.
14. Doeppner T.R., et al. Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice. Cell Death Dis. 2014, 5:e1386.
15. Dong W., et al. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J. Vasc. Surg. 2008, 48:709-714.
16. Famakin B.M. The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review. Aging Dis. 2014, 5:307-326.
17. Gao D., et al. Resveratrol protects primary cortical neuron cultures from transient oxygen-glucose deprivation by inhibiting MMP-9. Mol. Med. Rep. 2014, 9:2197-2204.
18. Gelderblom M., et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
19. Herz J., et al. Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol. Dis. 2014, 62:456-468.
20. Huang S.S., et al. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci. 2001, 69:1057-1065.
21. Huang T., et al. Resveratrol inhibits oxygen-glucose deprivation-induced MMP-3 expression and cell apoptosis in primary cortical cells via the NF-kappaB pathway. Mol. Med. Rep. 2014, 10:1065-1071.
22. Kennedy D.O., et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am. J. Clin. Nutr. 2010, 91:1590-1597.
23. Kodali M., et al. Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation. Sci. Rep. 2015, 5:8075.
24. Li Z., et al. Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. Brain Res. 2012, 1450:116-124.
25. Lu K.T., et al. Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J. Agric. Food Chem. 2006, 54:3126-3131.
26. Macrez R., et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011, 10:471-480.
27. Madhyastha S., et al. Resveratrol improves postnatal hippocampal neurogenesis and brain derived neurotrophic factor in prenatally stressed rats. Int. J. Dev. Neurosci. 2013, 31:580-585.
28. Mikulski D., et al. A theoretical study of the structure-radical scavenging activity of trans-resveratrol analogues and cis-resveratrol in gas phase and water environment. Eur. J. Med. Chem. 2010, 45:1015-1027.
29. Moriya J., et al. Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol. Pharm. Bull. 2011, 34:354-359.
30. Park H.R., et al. Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesis. J. Biol. Chem. 2012, 287:42588-42600.
31. Ren J., et al. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem. Res. 2011, 36:2352-2362.
32. Sakata Y., et al. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp. Neurol. 2010, 224:325-329.
33. Shah F.A., et al. Proteomic identification of proteins differentially expressed in response to resveratrol treatment in middle cerebral artery occlusion stroke model. J. Vet. Med. Sci. 2014, 76:1367-1374.
34. Shin J.A., et al. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J. Neuroimmunol. 2010, 227:93-100.
35. Shin J.A., et al. Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain. Neurochem. Res. 2012, 37:2686-2696.
36. Simao F., et al. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through PI3-K/Akt pathways. Eur. J. Neurosci. 2012, 36:2899-2905.
37. Simao F., et al. Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J. Cereb. Blood Flow Metab. 2012, 32:884-895.
38. Sun A.Y., et al. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol. Neurobiol. 2010, 41:375-383.
39. Tsai S.K., et al. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J. Vasc. Surg. 2007, 46:346-353.
40. Vidavalur R., et al. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp. Clin. Cardiol. 2006, 11:217-225.
41. Wang Q., et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002, 958:439-447.
42. Wang L.M., et al. A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia. Eur. J. Neurosci. 2013, 37:1669-1681.
43. Wightman E.L., et al. Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation. Br. J. Nutr. 2014, 112:203-213.
44. Witte A.V., et al. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J. Neurosci. 2014, 34:7862-7870.
45. Yousuf S., et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 2009, 1250:242-253.